Evidence map›Paper›PMID 29093747›Full record

ArticleChinese medicine2017

Hepatoprotective properties of

Meng Wang, Xiao-Jiao Zhang, Ruibing Feng, Yun Jiang, Da-Yong Zhang, Chengwei He, Peng Li, Jian-Bo Wan

Open access · goldAbstract read
In one paragraph

Article in Chinese medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Macroporous Resin Purification of Phenolics fromAntioxidants (Basel, Switzerland) · 2026
    Article
  3. Journal of pharmaceutical analysis · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. An Updated Review on Efficiency ofBioMed research international · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. An Overview of the Mechanism ofEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. CClEvidence-based complementary and alternative medicine : eCAM · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Meng Wang *State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Room 6034, Building N22, Avenida da Universidade, Macao, People's Republic of China.
Xiao-Jiao Zhang *State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Room 6034, Building N22, Avenida da Universidade, Macao, People's Republic of China.
Ruibing FengState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Room 6034, Building N22, Avenida da Universidade, Macao, People's Republic of China.
Yun JiangSichuan New Lotus Traditional Chinese Herb Limited Company, Chengdu, China.
Da-Yong ZhangSichuan New Lotus Traditional Chinese Herb Limited Company, Chengdu, China.
Chengwei HeState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Room 6034, Building N22, Avenida da Universidade, Macao, People's Republic of China.
Peng LiState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Room 6034, Building N22, Avenida da Universidade, Macao, People's Republic of China.
Jian-Bo WanState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Room 6034, Building N22, Avenida da Universidade, Macao, People's Republic of China.ORCID 0000-0002-6750-2617
University of Macau · MO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsC57BL/6 mice were orally administered an aqueous extract of PCP (5.15 and 10.3 g/kg BW) or silymarin (100 mg/kg) once daily for 1 week prior to CCl

resultsA single dose of CCl

conclusionResults indicated that the pretreatment of PCP (10.3 g/kg BW) effectively protected against CCl

Indexed as

Carbon tetrachlorideHepatotoxicityNuclear factor E2-related factor 2Oxidative stressPenthorum chinense Pursh

Identifiers

PMID29093747
PMCPMC5663075
OpenAlexW2766302604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.